Tang WW, Han ML, Xu SH, Deng YX, Shen Q. Analysis of sleep quality, disease uncertainty, and psychological tolerance in patients undergoing chemotherapy for digestive tract malignancies. World J Clin Cases 2024; 12(20): 4247-4255 [PMID: 39015909 DOI: 10.12998/wjcc.v12.i20.4247]
Corresponding Author of This Article
Wen-Wen Tang, MBBS, Chief Nurse, Department of Oncology, Hefei BOE Hospital, Intersection of Dongfang Avenue and Wenzhong Road, Xinzhan District, Hefei 230011, Anhui Province, China. 18226171624@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 3 Comparison of Mishel Uncertainty in Illness Scale for Adults scores between sleep disorder group and normal sleep group (mean ± SD)
Group
Lack of disease information
Disease uncertainty
Complexity
Unpredictability
Total score
Sleep disorders group (n = 78)
16.57 ± 1.68
46.25 ± 4.72
24.75 ± 2.54
10.13 ± 1.16
97.76 ± 9.82
Normal sleep group (n = 53)
13.26 ± 1.57
30.57 ± 3.26
16.54 ± 1.79
8.15 ± 0.83
68.53 ± 6.90
t
11.362
21.007
20.338
10.699
18.743
P value
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
Table 4 Comparison of Connor-Davidson Resilience Scale scores between sleep disorder group and normal sleep group (mean ± SD)
Group
Resilience
Self-improvement
Optimistic
Total score
Sleep disorders group (n = 78)
25.48 ± 2.63
17.15 ± 1.78
5.71 ± 0.61
48.32 ± 4.96
Normal sleep group (n = 53)
28.63 ± 2.97
18.96 ± 1.93
6.34 ± 0.65
53.93 ± 5.46
t
6.383
5.520
5.650
6.099
P value
< 0.001
< 0.001
< 0.001
< 0.001
Table 5 Correlation between Pittsburgh Sleep Quality Index score and Mishel Uncertainty in Illness Scale for Adults and Connor-Davidson Resilience Scale scores in chemotherapy patients with gastrointestinal malignant tumors
Variables
PSQI
r
P value
MUIS-A score
Lack of disease information
0.583
< 0.001
Disease uncertainty
0.422
0.008
Complexity
0.169
0.114
Unpredictability
0.426
0.006
CD-RISC score
Resilience
-0.579
< 0.001
Self-improvement
-0.613
< 0.001
Optimistic
-0.281
0.021
Table 6 Analysis of Factors Influencing Sleep Disorders in Chemotherapy Patients with Gastrointestinal Malignant Tumors
Factors
β
SE
Wald χ2
OR
P value
95%CI
Age
0.353
0.276
1.636
1.423
0.202
0.829-2.445
Chemotherapy frequency
0.255
0.184
1.921
1.290
0.167
0.900-1.851
Pain level
0.457
0.273
2.802
1.579
0.095
0.925-2.697
SAS score
0.291
0.115
6.403
1.338
0.012
1.068-1.676
SDS score
0.284
0.118
5.793
1.328
0.017
1.054-1.674
Ward noise
0.365
0.176
4.301
1.441
0.039
1.020-2.034
MUIS-A score
0.357
0.148
5.819
1.429
0.016
1.069-1.910
CD-RISC score
-0.426
0.106
16.151
0.653
< 0.001
0.531-0.804
Citation: Tang WW, Han ML, Xu SH, Deng YX, Shen Q. Analysis of sleep quality, disease uncertainty, and psychological tolerance in patients undergoing chemotherapy for digestive tract malignancies. World J Clin Cases 2024; 12(20): 4247-4255